David Palmer is a Lecturer in the Department of Chemistry of the University of Strathclyde.
He obtained his PhD in Chemistry from Cambridge University in 2008 for work on computational drug discovery under the supervision of Dr. John Mitchell. This research was carried out in the Centre for Molecular Informatics and was funded by Pfizer Inc. through the Pfizer Institute for Pharmaceutical Materials.
He holds a Masters degree in Chemistry from the University of Sheffield, where he worked on computational modeling of sequence-dependent DNA structure in the group of Prof. Christopher A. Hunter.
After completing his doctorate, David carried out postdoctoral research on protein biochemistry with Prof Frank Jensen and Prof Birgit Schiott at Aarhus University in Denmark and on solvation thermodynamics with Prof Maxim V. Fedorov at the Max Planck Institute for Mathematics in the Sciences in Leipzig, Germany.
In 2012, he was awarded a Marie Curie Intra-European Fellowship and moved to the Department of Physics at the University of Strathclyde. He has been a Lecturer in the Department of Chemistry since the beginning of 2014. He currently leads a research group applying theory, simulation and informatics methods to study the chemistry of complex biological systems.
He is co-Founder and Director of ClinSpec Dx, a biomedical spinout company that is developing cost-effective diagnostics for cancer (www.clinspecdx.com).